2012
Rare Subtypes of Extranodal T-Cell Lymphoma
Lansigan F, Hudnall S, Foss F. Rare Subtypes of Extranodal T-Cell Lymphoma. Contemporary Hematology 2012, 105-112. DOI: 10.1007/978-1-62703-170-7_7.Peer-Reviewed Original ResearchT-cell lymphomaPoor outcomePanniculitis-like T-cell lymphomaExtranodal T-cell lymphomasCytotoxic T-cell lymphomaHepatosplenic T-cell lymphomaRare T-cell lymphomaAggressive T-cell lymphomaConventional therapeutic approachesInflammatory panniculitisImmunosuppressive therapyExcellent prognosisAutoimmune disordersRare subtypeCeliac sprueTissue trophismTherapeutic approachesNew agentsLymphomaIsochromosome 7qMorphologic typesDisordersOutcomesPanniculitisPrognosis
1996
MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Hudnall1 2, Kathleen M, A. G, Yvonne B. MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE. Transplantation 1996, 61: 1776-1778. PMID: 8685960, DOI: 10.1097/00007890-199606270-00020.Peer-Reviewed Original ResearchConceptsPericardial effusionLymphocytic effusionsLymphoproliferative disordersB-cell lymphoproliferative disordersBenign pericardial effusionCardiac transplant teamPosttransplant lymphoproliferative diseaseCardiac transplant recipientsCell lymphoproliferative disordersImmunosuppressant withdrawalTransplant recipientsTransplant settingLymphoproliferative diseaseTransplant teamOpposite therapyImmunophenotypic dataTransplant processUnusual caseEffusionDetailed histologicDiagnostic distinctionEBVDisorders
1992
Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy
Canfield C, Hudnall S, Colonna J, Busuttil R, Wilkinson A, Danovitch G, Shaked A, Goldstein L, Rosenthal J. Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy. Clinical Transplantation 1992, 6: 1-9. DOI: 10.1111/j.1399-0012.1992.tb00580.x.Peer-Reviewed Original ResearchPost-transplant lymphoproliferative disorderLymphoproliferative disordersEpstein-Barr virus-associated post-transplant lymphoproliferative disorderAssociated with Epstein-Barr virusOKT3 monoclonal antibody therapySequelae of immunosuppressionWithdrawal of immunosuppressionMonoclonal antibody therapyPeripheral blood smearEpstein-Barr virusOKT3 therapyAtypical lymphocytesMalignant lymphomaAntibody therapyClinical spectrumProphylactic useImmunosuppressionOKT3Medical CenterBlood smearsAcyclovirTherapyDisordersLymphomaLymphocytes